Sec Form 4 Filing - Becker Joel @ ST JUDE MEDICAL INC - 2012-04-06

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Becker Joel
2. Issuer Name and Ticker or Trading Symbol
ST JUDE MEDICAL INC [ STJ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President - USD
(Last) (First) (Middle)
ONE ST. JUDE MEDICAL DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
04/06/2012
(Street)
ST. PAUL, MN55117
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/06/2012 M 249 A 1,111 D
Common Stock 04/06/2012 F 82 ( 7 ) D $ 40.97 1,029 D
Common Stock 10/31/2012 M 875 A 1,904 D
Common Stock 10/31/2012 F 233 ( 8 ) D $ 38.26 1,671 D
Common Stock 10/24/2013 S 1,135 D $ 56.5 3,715 ( 4 ) D
Common Stock 10/24/2013 M 5,332 A $ 41.65 9,047 D
Common Stock 10/24/2013 S 5,332 D $ 56.48 ( 2 ) 3,715 D
Common Stock 10/24/2013 S 3,146 D $ 56.47 ( 3 ) 569 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units ( 5 ) 04/06/2012 M 249 04/06/2012 ( 6 ) Common Stock 996 $ 0 747 D
Restricted Stock Units ( 5 ) 10/31/2012 M 875 10/31/2012 ( 6 ) Common Stock 3,500 $ 0 2,625 D
Stock Option (Right to Buy) $ 41.65 10/24/2013 M 5,332 12/14/2011( 1 ) 12/14/2018 Common Stock 10,664 $ 0 5,332 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Becker Joel
ONE ST. JUDE MEDICAL DRIVE
ST. PAUL, MN55117
President - USD
Signatures
/s/ Kashif Rashid, Attorney in Fact 10/28/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Fully vested at the time of filing.
( 2 )The price in Column 4 is a weighted average. The prices actually received ranged from $56.47 to $56.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 3 )The price in Column 4 is a weighted average. The prices actually received ranged from $56.47 to $56.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 4 )The total number of securities beneficially owned has been adjusted to correctly reflect that 573 shares (rather than 708 shares) were withheld to pay taxes in connection with a transaction described on Mr. Becker's Form 4 filed on Dec 14, 2012.
( 5 )Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
( 6 )The restricted stock units will vest 25% on each of the first four anniversary dates of the date of the grant beginning the date shown.
( 7 )249 shares of restricted stock vested on April 6, 2012. 82 shares were used to pay taxes and 167 were released.
( 8 )875 shares of restricted stock vested on April 6, 2012. 233 shares were used to pay taxes and 642 were released.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.